Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now NasdaqCM - Delayed Quote • USD LakeShore Biopharma Co., Ltd (LSBPW) Follow Compare 0.0546 +0.0186 +(51.67%) As of April 10 at 4:00:00 PM EDT. Market Open. Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for LSBPW 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: LSBPW View More All News Press Releases SEC Filings LakeShore Biopharma Reports Unaudited Financial Results for the First Half of Fiscal Year 2025 and Updates Full-Year Guidance LakeShore Biopharma Provides Update on Ongoing Criminal Investigation Involving Former Chairman in China LakeShore Biopharma Initiates Biologics License Application of PIKA Rabies Vaccine to the Drug Regulatory Authority of Pakistan LakeShore Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement LakeShore Biopharma Advances with Rabies Vaccine Trial LakeShore Biopharma Granted Phase III Clinical Trial Approval to Explore Simplified Regimens for YSJA Rabies Vaccine LakeShore Biopharma Provides Fiscal Half Year 2025 Financial Guidance and Reaffirms Fiscal Year 2025 Financial Guidance LakeShore Biopharma Announces Results of Extraordinary General Meeting on Share Consolidation Lakeshore Biopharma to Hold an Extraordinary General Meeting of Shareholders on September 27, 2024 LakeShore Biopharma Announces Leadership Transitions LakeShore Biopharma Announces Financial Results for Fiscal Year 2024